table of content
1 Introduction to Research & Analysis Reports
1.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Overall Market Size
2.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size: 2022 VS 2029
2.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Small Cell Lung Cancer Treatment (NSCLC) Players in Global Market
3.2 Top Global Non-Small Cell Lung Cancer Treatment (NSCLC) Companies Ranked by Revenue
3.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue by Companies
3.4 Top 3 and Top 5 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Small Cell Lung Cancer Treatment (NSCLC) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Players in Global Market
3.6.1 List of Global Tier 1 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Markets, 2022 & 2029
4.1.2 Angiogenesis Inhibitor
4.1.3 Epidermal Growth Factor Receptor Blocker
4.1.4 Kinase Inhibitor
4.1.5 Microtubule Stabilizer
4.1.6 Folate Antimetabolites
4.1.7 Others
4.2 By Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
4.2.1 By Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2023
4.2.2 By Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2024-2029
4.2.3 By Type - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2022 & 2029
5.1.2 Adenocarcinoma
5.1.3 Squamous Cell Carcinoma
5.1.4 Large Cell Carcinoma
5.2 By Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
5.2.1 By Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2023
5.2.2 By Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2024-2029
5.2.3 By Application - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2022 & 2029
6.2 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue & Forecasts
6.2.1 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2023
6.2.2 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2024-2029
6.2.3 By Region - Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2029
6.3.2 US Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.3.3 Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.3.4 Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2029
6.4.2 Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.3 France Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.4 U.K. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.5 Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.6 Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.7 Nordic Countries Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.4.8 Benelux Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2029
6.5.2 China Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.5.3 Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.5.4 South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.5.5 Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.5.6 India Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2029
6.6.2 Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.6.3 Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue, 2018-2029
6.7.2 Turkey Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.7.3 Israel Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.7.4 Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
6.7.5 UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size, 2018-2029
7 Non-Small Cell Lung Cancer Treatment (NSCLC) Companies Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.1.4 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.2.4 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.3.4 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Avid Bioservices Inc.
7.4.1 Avid Bioservices Inc. Company Summary
7.4.2 Avid Bioservices Inc. Business Overview
7.4.3 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.4.4 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.4.5 Avid Bioservices Inc. Key News & Latest Developments
7.5 Bayer Healthcare
7.5.1 Bayer Healthcare Company Summary
7.5.2 Bayer Healthcare Business Overview
7.5.3 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.5.4 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.5.5 Bayer Healthcare Key News & Latest Developments
7.6 Biogen Inc.
7.6.1 Biogen Inc. Company Summary
7.6.2 Biogen Inc. Business Overview
7.6.3 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.6.4 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.6.5 Biogen Inc. Key News & Latest Developments
7.7 Blueprint Medicines Corp
7.7.1 Blueprint Medicines Corp Company Summary
7.7.2 Blueprint Medicines Corp Business Overview
7.7.3 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.7.4 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.7.5 Blueprint Medicines Corp Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.8.4 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Merck & co Inc.
7.9.1 Merck & co Inc. Company Summary
7.9.2 Merck & co Inc. Business Overview
7.9.3 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.9.4 Merck & co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.9.5 Merck & co Inc. Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.10.4 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Company Summary
7.11.2 Pfizer Inc. Business Overview
7.11.3 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Major Product Offerings
7.11.4 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in Global Market (2018-2023)
7.11.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
